Regen BioPharma, Inc. to Present at the Emerging Growth Conference on February 22, 2023

Rhea-AI Summary

Regen BioPharma, Inc. (OTC PINK: RGBP, RGBPP) is set to present at the Emerging Growth Conference on February 22, 2023, from 2:40 to 2:50 PM Eastern Time. This live event will provide a platform for interaction with CEO Dr. David Koos, where shareholder questions will be addressed. Key discussion points include updates on a pending reverse stock split and future financing plans. Registration is available for real-time participation and an archived webcast will also be accessible post-event. The conference showcases companies in growth sectors and aims to connect them with investors.

Regen BioPharma, Inc. invites individual and institutional investors as well as advisors and analysts to attend its real-time, interactive presentation at the Emerging Growth Conference.

SAN DIEGO, Feb. 21, 2023 /PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP) (a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA vaccines, RNA and DNA therapeutics and small molecule drugs) will be presenting at the Emerging Growth Conference on February 22, 2023 (https://emerginggrowth.com/conference/).

This live interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company's CEO, Dr. David Koos, in real time. Please ask your questions during the event and Dr. Koos and his team will do their best to address as many of them as possible.

"We plan to use this time to update our stakeholders regarding the Company's pending  reverse stock split, discuss our future financing and programmatic plans and answer shareholder questions," says Dr. David Koos, CEO and Chairman of the Company. 

Regen BioPharma, Inc. will be presenting from 2:40 – 2:50 Eastern Time on Wednesday, February 22, 2023. Please register here to ensure you are able to attend the conference and receive any updates that are released https://goto.webcasts.com/starthere.jsp?ei=1595541&tp_key=7d6588b9a9&sti=rgbp. 

For those unable to join the event live on the day of the conference an archived webcast will also be made available on EmergingGrowth.com.

About the Emerging Growth Conference:

The Emerging Growth conference is an effective way for public companies to present and communicate their new products, services and other major announcements to the investment community from the convenience of their office, in a time efficient manner.

The Conference focus and coverage includes companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long term growth. Its audience includes potentially tens of thousands of individual and institutional investors, as well as investment advisors and analysts.

About Regen BioPharma Inc.: 

Regen BioPharma, Inc. is a publicly traded biotechnology company (PINK: RGBP) and (PINK: RGBPP). The Company is focused on the immunology and immunotherapy space. The Company is focused on rapidly advancing novel technologies through pre-clinical and Phase I/ II clinical trials. Currently, the Company is focused on mRNA and small molecule therapies for treating cancer and autoimmune disorders. Additional information on Regen BioPharma is available at http://www.regenbiopharmainc.com.

Disclaimer: This news announcement may contain forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.

Contact Information:

Regen BioPharma Inc.
David R. Koos, Ph.D.
Chairman & Chief Executive Officer
+1-619-722-5505 Phone
+1-619-330-2328 Fax
Email: david.koos@regenbiopharmainc.com

Follow us on Twitter for future updates: https://twitter.com/TheRegenBio

 

View original content:https://www.prnewswire.com/news-releases/regen-biopharma-inc-to-present-at-the-emerging-growth-conference-on-february-22-2023-301751425.html

SOURCE Regen BioPharma Inc.

FAQ

What is the date of Regen BioPharma's presentation at the Emerging Growth Conference?

Regen BioPharma will present at the Emerging Growth Conference on February 22, 2023.

What time will Regen BioPharma's presentation take place?

Regen BioPharma's presentation is scheduled for 2:40 PM to 2:50 PM Eastern Time.

How can investors participate in Regen BioPharma's presentation?

Investors can register to participate in Regen BioPharma's presentation at the Emerging Growth Conference through the provided registration link.

What topics will Regen BioPharma cover during the conference?

Regen BioPharma will discuss a pending reverse stock split, future financing, and programmatic plans.

Will there be an archived version of Regen BioPharma's presentation available?

Yes, an archived webcast of the presentation will be made available on EmergingGrowth.com.

What are the stock symbols for Regen BioPharma?

Regen BioPharma is traded under the stock symbols RGBP and RGBPP.